Glioma Mesoscopic Imaging

Glioma Mesoscopic Imaging - GlioMI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005580

Enrollment

Registered

2014-06-18

Start date

2014-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71.9 D43.2

Interventions

Group 1: In this single arm study, mesoscopic imaging of gliomas wil be performed before stereotactic biopsy. Tumour borders from histology will be compared to mesoscopic metrics (extraaxial water and

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with suspected glioma (low grade, anaplastic,GBM) prior to stereotactic biopsy - Patients with a known but presumably progressive glioma prior to re-biopsy

Exclusion criteria

Exclusion criteria: Unability to cosent - Minor - Any contraindication against MRI - Renal Insufficiency (GFR < 30 ml/min x 1.73)

Design outcomes

Secondary

Measure	Time frame
Tumour progression according to RANO criteria within the 3-monthly follow-up investigations. The time point of progressive disease is individual for each participant.	—

Primary

Measure	Time frame
Stereotactic biopsy: comparison of histologically proven infiltration and mesoscopic parameters	—

Countries

Germany

Contacts

Public ContactUlrike Bergmann

Universitätsklinikum Freiburg - Klinik für Neuroradiologie

ulrike.bergmann@uniklinik-freibrug.de0761 270 51930

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026